Comparative assessment of different central venous access devices in patients with hemoblastosis

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Kalinina S.L.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Lyanguzov A.V.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Sergunina O.Yu.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Ignatyev S.V.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Kovtunova M.E.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Minaeva N.V.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Paramonov I.V.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Comparative assessment of different central venous access devices in patients with hemoblastosis

Authors:

Kalinina S.L., Lyanguzov A.V., Sergunina O.Yu., Ignatyev S.V., Kovtunova M.E., Minaeva N.V., Paramonov I.V.

More about the authors

Journal: Russian Journal of Anesthesiology and Reanimatology. 2021;(4): 91‑96

DOI: 10.17116/anaesthesiology202104191

Views: 1150

Downloaded: 64

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kalinina SL, Lyanguzov AV, Sergunina OYu, Ignatyev SV, Kovtunova ME, Minaeva NV, Paramonov IV. Comparative assessment of different central venous access devices in patients with hemoblastosis. Russian Journal of Anesthesiology and Reanimatology. 2021;(4):91‑96. (In Russ.)
https://doi.org/10.17116/anaesthesiology202104191

Подписка 2025 (АиР)

Close metadata

Recommended articles:

Optimal prevention of VTE in cancer surgery patients with impaired renal function. Pirogov Russian Journal of Surgery. 2024;(1):119-126

Modern operative gynecology in geriatric patients. Russian Journal of Human Reproduction. 2024;(1):10-25

Fertility-sparing treatment in cancer patients: how can we help in the 21st century?. Russian Journal of Human Reproduction. 2024;(1):26-63

Uncontrolled inhibition of checkpoints. P.A. Herzen Journal of Oncology. 2024;(2):67-73

Pre-rehabilitation of oncological patients before extensive abdominal and thoracic surgery: a literature review. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(2):46-56

Relationship between pregnancy and the risk of malignant neoplasms of the female reproductive system. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):48-54

Tumor models in cancer research. P.A. Herzen Journal of Oncology. 2024;(4):72-76

Influence of the ISO standard 9001 on performance of medical organizations: a systematic review. Medical Technologies. Assessment and Choice. 2024;(3):43-52

Cost of supportive cancer care in the Russian Federation. Part 1. Medical Technologies. Assessment and Choice. 2024;(3):93-103

Statistical analysis of complaints in primary and secondary rhinoplasty. Plastic Surgery and Aesthetic Medicine. 2024;(3):28-35

OBJECTIVE

To analyze economic efficiency of various central venous access devices and quality of life associated with their use in patients with hemoblastosis.

MATERIAL AND METHODS

The study included 154 patients of Hematology Hospital of the Kirov Research Institute of Hematology and Blood Transfusion with various central venous access devices installed in 2017-2019. Group 1 included patients with non-tunneled, tunneled central venous catheters (CVCs) and peripherally implantable central venous catheters (PIC catheters), group 2 — patients with totally implantable venous access port systems (TIVAPS). We analyzed time of insertion of each type of device, cost per 1 catheter-day and patient subjective assessment of central venous access devices (Likert scale).

RESULTS

CVCs have been used for 21.5±5.8 days, tunneled CVCs — 152.2±28.4 days, PIC catheters — 97.7±20.1 days, port systems — 589.3±225.7 days. Time of TIVAPS insertion was significantly longer compared to devices with cutaneous placement of proximal part of catheter (F=5.33; p=0.000). The cost of TIVAPS was the lowest compared to other devices per 1 catheter-day. TIVAPS cause less discomfort at the site of installation (p=0.03) and limit daily life opportunities of patients to a lesser extent compared to systems with cutaneous arrangement of proximal part of catheter (p=0.012).

CONCLUSION

TIVAPS optimizes the cost of venous access in patients with hemoblastosis considering long-term period of treatment. Venous port systems in patients with hemoblastosis minimally restrict daily activity of patients and ensure an acceptable quality of life.

Keywords:

hematology

oncology

central venous access

totally implantable venous access port systems

cost effectiveness

patient satisfaction

Authors:

Kalinina S.L.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Lyanguzov A.V.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Sergunina O.Yu.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Ignatyev S.V.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Kovtunova M.E.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Minaeva N.V.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Paramonov I.V.

Kirov Research Institute of Hematology and Blood Transfusion of the FMBA of Russia

Received:

22.01.2021

Accepted:

14.02.2021

List of references:

Youn JK, Jung K, Park T, Kim HY, Jung SE. The effect of Absolute Neutrophil Count (ANC) on early surgical site infection in Implanted Central Venous Catheter (ICVC). Journal of Pediatric Surgery. 2020;55(7):1344-1346. https://doi.org/10.1016/j.jpedsurg.2019.09.035
Rykov MY, Polyakov VG. Implantable venous ports in pediatric oncology: experience of single institution in Russia. The Journal of Vascular Access. 2016;17(4):345-347. https://doi.org/10.5301/jva.5000556
Sakai T, Kohda K, Konuma Y, Hiraoka Y, Ichikawa Y, Ono K, Horiguchi H, Tatekoshi A, Takada K, Iyama S, Kato J. A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies. International Journal of Hematology. 2014;100(6):592-598. https://doi.org/10.1007/s12185-014-1677-9
Cesaro S, Cavaliere M, Pegoraro A, Gamba P, Zadra N, Tridello G. A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients. Annals of Hematology. 2016;95(5):817-825. https://doi.org/10.1007/s00277-016-2634-x
Lyanguzov AV, Kalinina SL, Sergunina OYu, Ignatyev SV, Tselousova OM, Vaskina EA, Tataurova IP. Use of totally implantable venous port systems in children hematology clinic. Rossijskij zhurnal detskoj gematologii i onkologii. 2020;7(2):35-41. (In Russ.). https://doi.org/10.21682/2311-1267-2020-7-2-35-41
Heibl C, Trommet V, Burgstaller S, Mayrbaeurl B, Baldinger C, Koplmüller R, Kühr T, Wimmer L, Thaler J. Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. European Journal of Cancer Care. 2010;19(5):676-681. https://doi.org/10.1111/j.1365-2354.2009.01115.x
Rykov MYu, Men TKh, Susuleva NA, Polyakov VG. Venous Access in Treating Children with Cancer: 5-years Experience of the Institute of Pediatric Oncology and Hematology. Onkopediatriya. 2015;2(3):193-204. (In Russ.). https://doi.org/10.15690/onco.v2.i3.1397
Lyanguzov AV, Kolotilov LV, Zagoskina TP. Rhabdomyolysis in Patients with Hemoblastoses during Intensive Chemotherapy. Obshchaya reanimatologiya. 2009;5(4):60-65. (In Russ.). https://doi.org/10.15360/1813-9779-2009-4-60
O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clinical Infectious Diseases. 2011;52(9):162-193. https://doi.org/10.1093/cid/cir257
Hansen BA, Wendelbo Ø, Bruserud Ø, Hemsing AL, Mosevoll KA, Reikvam H. Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment. Mediterranean Journal of Hematology and Infectious Diseases. 2020;12(1):e2020009. https://doi.org/10.4084/MJHID.2020.009
Rajendranath R, Balasubramaniyum VK, Vijayakumar V, Ganesan P, Tenali GS. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India. Indian Journal of Cancer. 2014;51(4):481-486. https://doi.org/10.4103/0019-509X.175303
Samaras P, Dold S, Braun J, Kestenholz P, Breitenstein S, Imhof A, Renner C, Stenner-Liewen F, Pestalozzi BC. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology. 2008;74(3-4):237-244. https://doi.org/10.1159/000151393
Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clinical Microbiology Reviews. 2007;20(1):133-163. https://doi.org/10.1128/CMR.00029-06
Girmenia C, Finolezzi E, Federico V, Santopietro M, Perrone S. Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: current epidemiology and therapeutic options. Mediterranean Journal of Hematology and Infectious Diseases. 2011;3(1):e2011013. https://doi.org/10.4084/MJHID.2011.013
Kimura M, Araoka H, Yamamoto H, Asano-Mori Y, Nakamura S, Yamagoe S, Ohno H, Miyazaki Y, Abe M, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Izutsu K, Wake A, Taniguchi S, Yoneyama A. Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital. Antimicrobial Agents and Chemotherapy. 2017;61(4):e01791-16. https://doi.org/10.1128/AAC.01791-16
Spirin MV, Galstyan GM, Drokov MYu, Kuzmina LA, Klyasova GA, Parovichnikova EN, Savchenko VG. Provision of central venous access during allogenic haematopoetic stem cell transplantation. Gematologiya i transfuziologiya. 2019;64(4):396-411. (In Russ.). https://doi.org/10.35754/0234-5730-2019-64-4-396-411
Perez AW, Watchmaker JM, Brown DB, Banovac F. Association between Periprocedural Neutropenia and Early Infection-related Chest Port Removal. Radiology. 2019;291(2):513-518. https://doi.org/10.1148/radiol.2019182175
Johnson EJ. Is It Appropriate to Place Subcutaneous Chest Ports in Patients with Neutropenia? Radiology. 2019;291(2):519-520. https://doi.org/10.1148/radiol.2019190095
VanHouwelingen LT, Veras LV, Lu M, Wynn L, Wu J, Prajapati HJ, Gold RE, Murphy AJ, Fernandez-Pineda I, Gosain A, Pui CH, Davidoff AM. Neutropenia at the time of subcutaneous port insertion may not be a risk factor for early infectious complications in pediatric oncology patients. Journal of Pediatric Surgery. 2019;54(1):145-149. https://doi.org/10.1016/j.jpedsurg.2018.10.024
Falanga A, Schieppati F, Russo L. Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients. Cancer Treatment and Research. 2019;179: 11-36. https://doi.org/10.1007/978-3-030-20315-3_2
Ignatyev SV, Zotina EN, Fokina ES, Lyanguzov AV, Lagunova OR, Ivashkina EP. Procoagulantive state in patients with non-Hodgkin’s lymphomas. Tromboz, gemostaz i reologiya. 2018;3(75):35-40. (In Russ.). https://doi.org/10.25555/THR.2018.3.0849
Tran H, Arellano M, Chamsuddin A, Flowers C, Heffner LT, Langston A, Lechowicz MJ, Tindol A, Waller E, Winton EF, Khoury HJ. Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leukemia and Lymphoma. 2010;51(8):1473-1477. https://doi.org/10.3109/10428194.2010.481065
Taxbro K, Hammarskjöld F, Thelin B, Lewin F, Hagman H, Hanberger H, Berg S. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. British Journal of Anaesthesia. 2019;122(6):734-741. https://doi.org/10.1016/j.bja.2019.01.038
Okazaki M, Oyama K, Kinoshita J, Miyashita T, Tajima H, Takamura H, Ninomiya I, Fushida S, Ohta T. Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: A retrospective analysis. Molecular and Clinical Oncology. 2019;11(4):343-348. https://doi.org/10.3892/mco.2019.1897
Lyanguzov AV, Kalinina SL, Sergunina OYu, Ignatyev SV, Rasin MP. Experience of using totally implantable venous access devices in patients with hemoblastosis. Meditsinskij vestnik Severnogo Kavkaza. 2020;15(4):484-488. (In Russ.). https://doi.org/10.14300/mnnc.2020.15113
Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. European Journal of Cancer and Clinical Oncology. 1989;25(6):939-944. https://doi.org/10.1016/0277-5379(89)90151-x
Wu O, Boyd K, Paul J, McCartney E, Ritchie M, Mellon D, Kelly L, Dixon-Hughes J, Moss J. Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation. British Journal of Cancer. 2016;114(9):979-985. https://doi.org/10.1038/bjc.2016.76

Close metadata

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.